{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:06:23Z","timestamp":1747285583332},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4506,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1046\/j.1365-2133.2003.05286.x","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T01:35:16Z","timestamp":1103592916000},"page":"885-891","source":"Crossref","is-referenced-by-count":12,"title":["Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis"],"prefix":"10.1093","volume":"148","author":[{"given":"R.","family":"Gniadecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/smim.1998.0144","article-title":"Tumor necrosis factor receptor family members in the immune system","volume":"10","author":"Gravestein","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/90942","article-title":"Signaling through OX40 (CD134) breaks peripheral T-cell tolerance","volume":"7","author":"Bansal-Pakala","year":"2001","journal-title":"Nat Med"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB4","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1101\/gad.12.18.2821","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs)\ufffd\ufffd\ufffda family of adapter proteins that regulates life and death","volume":"12","author":"Arch","year":"1998","journal-title":"Genes Dev"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)80391-X","article-title":"Early lethality, functional NF-\ufffd\ufffdB activation, and increased sensitivity to TNF induced cell death in TRAF2 deficient mice","volume":"7","author":"Yeh","year":"1997","journal-title":"Immunity"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin 1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/1074-7613(94)90106-6","article-title":"The mouse Fas ligand gene is mutated in gld mice and is part of a TNF family gene cluster","volume":"1","author":"Lynch","year":"1994","journal-title":"Immunity"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Aruffo","year":"1993","journal-title":"Cell"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/361541a0","article-title":"CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM","volume":"361","author":"DiSanto","year":"1993","journal-title":"Nature"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.7679801","article-title":"CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome","volume":"259","author":"Allen","year":"1993","journal-title":"Science"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/10428190109097644","article-title":"Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma","volume":"40","author":"Jones","year":"2001","journal-title":"Leuk Lymph"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB14","first-page":"177","article-title":"Formalin resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas","volume":"135","author":"Hauschild","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin- and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2559.1990.tb01151.x","article-title":"The diagnostic significance of the CD30 (Ki 1) antigen","volume":"16","author":"Pallesen","year":"1990","journal-title":"Histopathology"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB17","first-page":"315","article-title":"Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease associated antigens","volume":"119","author":"Kadin","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB18","first-page":"1169","article-title":"Prognostic significance of CD30 (Ki-1\/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients","volume":"135","author":"Beljaards","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB19","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB21","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V83.8.2045.2045","article-title":"Pleiotropic effects of the CD30 ligand on CD30 expressing cells and lymphoma cell lines","volume":"83","author":"Gruss","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0161-5890(87)90122-2","article-title":"Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4-positive T blasts","volume":"24","author":"Paterson","year":"1987","journal-title":"Mol Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/eji.1830260805","article-title":"OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand","volume":"26","author":"Al-Shamkhani","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB24","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.4049\/jimmunol.163.12.6520","article-title":"Robust B-cell immunity but impaired T-cell proliferation in the absence of CD134 (OX40)","volume":"63","author":"Pippig","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm0296-183","article-title":"Selective depletion of myelin reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis","volume":"2","author":"Weinberg","year":"1996","journal-title":"Nat Med"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4049\/jimmunol.162.1.486","article-title":"Regulation of T cell activation in vitro and in vivo by targeting the OX40\ufffd\ufffd\ufffdOX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein","volume":"162","author":"Higgins","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB27","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2133.1982.tb00331.x","article-title":"The clinical and histological spectrum of lymphomatoid papulosis","volume":"107","author":"Willemze","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1097-0320(19990301)35:3<260::AID-CYTO9>3.0.CO;2-O","article-title":"Heat pretreatment increases resolution in DNA flow cytometry of paraffin embedded tumor tissue","volume":"35","author":"Leers","year":"1999","journal-title":"Cytometry"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB30","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X","article-title":"Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis","volume":"86","author":"Wang","year":"1999","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2133.1992.tb00106.x","article-title":"The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas","volume":"126","author":"Beljaards","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0190-9622(83)70011-3","article-title":"The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases","volume":"8","author":"Sanchez","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB33","first-page":"197","article-title":"Lymphomatoid papulosis: a follow-up study of 41 patients","volume":"13","author":"Christensen","year":"1994","journal-title":"Semin Dermatol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1365-2141.1995.tb05413.x","article-title":"Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues","volume":"91","author":"Durkop","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB35","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1182\/blood.V93.10.3487.410k39_3487_3493","article-title":"The T-cell activation markers CD30 and OX40\/CD134 are expressed in nonoverlapping subsets of peripheral T cell lymphoma","volume":"93","author":"Jones","year":"1999","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/intimm\/10.4.453","article-title":"The OX 40 receptor provides a potent costimulatory signal capable of inducing encephalitogenicity in myelin specific CD4+ T cells","volume":"10","author":"Kaleeba","year":"1998","journal-title":"Int Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0190-9622(94)70019-2","article-title":"Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T cell receptor gene rearrangement studies","volume":"30","author":"El-Azhary","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(01)00191-1","article-title":"OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells","volume":"15","author":"Rogers","year":"2001","journal-title":"Immunity"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9610(97)00139-6","article-title":"Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers","volume":"174","author":"Vetto","year":"1997","journal-title":"Am J Surg"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB40","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.4049\/jimmunol.166.3.2108","article-title":"Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells","volume":"166","author":"Nohara","year":"2001","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2003.05286.x-BIB41","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1182\/blood.V98.10.3162","article-title":"Correlation of peripheral blood OX40+ (CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Kotani","year":"2001","journal-title":"Blood"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2003.05286.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2003.05286.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:30:29Z","timestamp":1682901029000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/148\/5\/885\/6634773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05286.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}